Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer

Gastroenterology

Volumn 139, Issue 2, 2010, Pages

  Dong, Xiaoqun ^a   Javle, Milind ^a   Hess, Kenneth R ^a   Shroff, Rachna ^a   Abbruzzese, James L ^a   Li, Donghui ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Insulin Like Growth Factor Axis; Overall Survival; Pancreatic Cancer; Single Nucleotide Polymorphism

Indexed keywords

DNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; INSULIN RECEPTOR SUBSTRATE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL EVALUATION; CORRELATION ANALYSIS; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME; VALIDATION PROCESS; ADENOCARCINOMA; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PANCREAS TUMOR; PHASE 2 CLINICAL TRIAL; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; CLINICAL TRIALS, PHASE II AS TOPIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECEPTORS, SOMATOMEDIN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIGNAL TRANSDUCTION; SOMATOMEDINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955497635     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.04.042     Document Type: Article

References (34)

1. A. Jemal, R. Siegel, E. Ward, et al. Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. M.A. Morgan, L.A. Parsels, J. Maybaum, et al. Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review Clin Cancer Res 14 2008 6744 6750
3. D.J. Withers, D.J. Burks, H.H. Towery, et al. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling Nat Genet 23 1999 32 40
4. X. Dong, S. Park, X. Lin, et al. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth J Clin Invest 116 2006 101 114
5. A.A. Samani, S. Yakar, D. LeRoith, et al. The role of the IGF system in cancer growth and metastasis: overview and recent insights Endocr Rev 28 2007 20 47
6. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 2008 915 928
7. E. Buck, A. Eyzaguirre, M. Rosenfeld-Franklin, et al. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors Cancer Res 68 2008 8322 8332
8. M. Guix, A.C. Faber, S.E. Wang, et al. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins J Clin Invest 118 2008 2609 2619
9. X. Cui, H.J. Kim, I. Kuiatse, et al. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration Cancer Res 66 2006 5304 5313
10. T.W. Bauer, R.J. Somcio, F. Fan, et al. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells Mol Cancer Ther 5 2006 1676 1682
11. E.Y. Skolnik, A. Batzer, N. Li, et al. The function of GRB2 in linking the insulin receptor to Ras signaling pathways Science 260 1993 1953 1955
12. F.E. Bertrand, L.S. Steelman, W.H. Chappell, et al. Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells Leukemia 20 2006 1254 1260
13. J.M. Knowlden, H.E. Jones, D. Barrow, et al. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance Breast Cancer Res Treat 111 2008 79 91
14. C.S. Mitsiades, N.S. Mitsiades, C.J. McMullan, et al. Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors Cancer Cell 5 2004 221 230
15. X. Dong, L. Jiao, Y. Li, et al. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer J Clin Oncol 27 2009 1592 1599
16. P.H. Lee, and H. Shatkay F-SNP: computationally predicted functional SNPs for disease association studies Nucleic Acids Res 36 2008 D820 D824
17. S. Pounds, and S.W. Morris Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values Bioinformatics 19 2003 1236 1242
18. A.V. Patel, I. Cheng, F. Canzian, et al. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3) PLoS One 3 2008 e2578
19. M.L. Shim, L.E. Levitt Katz, J. Davis, et al. Insulin-like growth factor binding protein-3 is a novel mediator of apoptosis in insulin-secreting cells Growth Horm IGF Res 14 2004 216 225
20. W. Chen, S. Wang, T. Tian, et al. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies Eur J Hum Genet 17 2009 1668 1675
21. B.M. Wolpin, D.S. Michaud, E.L. Giovannucci, et al. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer Cancer Res 67 2007 7923 7928
22. S.K. Johnson, R.A. Dennis, G.W. Barone, et al. Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray Mol Carcinog 45 2006 814 827
23. S.K. Johnson, and R.S. Haun Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth World J Gastroenterol 15 2009 3355 3366
24. M.L. Hribal, F. Tornei, A. Pujol, et al. Transgenic mice overexpressing human G972R IRS-1 show impaired insulin action and insulin secretion J Cell Mol Med 12 2008 2096 2106
25. O. Porzio, M. Federici, M.L. Hribal, et al. The Gly972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells J Clin Invest 104 1999 357 364
26. J.O. Clausen, T. Hansen, C. Bjorbaek, et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1 Lancet 346 1995 397 402
27. M.L. Hribal, M. Federici, O. Porzio, et al. The Gly→Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells J Clin Endocrinol Metab 85 2000 2004 2013
28. A.J. McGettrick, E.P. Feener, and C.R. Kahn Human insulin receptor substrate-1 (IRS-1) polymorphism G972R causes IRS-1 to associate with the insulin receptor and inhibit receptor autophosphorylation J Biol Chem 280 2005 6441 6446
29. F. Sentinelli, E. Filippi, M.G. Cavallo, et al. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation J Endocrinol 188 2006 271 285
30. U. Bergmann, H. Funatomi, M. Kornmann, et al. Increased expression of insulin receptor substrate-1 in human pancreatic cancer Biochem Biophys Res Commun 220 1996 886 890
31. T. Asano, Y. Yao, S. Shin, et al. Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells Cancer Res 65 2005 9164 9168
32. J. Kwon, S. Stephan, A. Mukhopadhyay, et al. Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta Cancer Res 69 2009 1350 1357
33. M. Neid, K. Datta, S. Stephan, et al. Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells J Biol Chem 279 2004 3941 3948
34. H.B. Schiller, A. Szekeres, B.R. Binder, et al. Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor Mol Biol Cell 20 2009 745 756